Impact of Enhanced External Counter-pulsation Therapy on Glycaemic Control in People With Prediabetes and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis

Figures

• 

  Figure 1:. The PRISMA flow diagram for the systematic review

• 

  Figure 2:. (a) Risk of bias graph: the review authors' judgements about each risk of bias item presented as percentages across all included studies. (b) Risk of bias summary: the review authors' judgements about each risk of bias item for each included study

• 

  Figure 3:. Forest plot highlighting the impact of enhanced external counter-pulsation therapy compared with passive control group (placebo) at completion of therapy on (a) glycated haemoglobin; (b) fasting plasma glucose; (c) 2 hour post-prandial glucose; (d) systolic blood pressure; (e) diastolic blood pressure; (f) body mass index; (g)interleukin-6; (h) high-sensitivity C-reactive protein

• 

  Figure 4:. Forest plot highlighting the impact of enhanced external-counterpulsation therapy compared with placebo or passive control group at 2–4 weeks on (a) glycated haemoglobin; (b) fasting plasma glucose; (c) systolic blood pressure; (d) diastolic blood pressure

• 

  Figure 5:. Forest plot highlighting the impact of enhanced external-counterpulsation therapy as compared with placebo or passive control group at completion of therapy at 7–12 weeks on (a) glycated haemoglobin; (b) fasting plasma glucose; (c) systolic blood pressure; (d) diastolic blood pressure